123 related articles for article (PubMed ID: 8148423)
1. Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemia.
Thalhammer F; Gisslinger H; Chott A; Haas O; Etele-Hainz A; Helbich T; Kusec R; Linkesch W; Simonitsch I; Strobl H
Ann Hematol; 1994 Feb; 68(2):97-9. PubMed ID: 8148423
[TBL] [Abstract][Full Text] [Related]
2. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemia.
Le XF; Claxton D; Kornblau S; Fan YH; Mu ZM; Chang KS
Eur J Haematol; 1998 Apr; 60(4):217-25. PubMed ID: 9579874
[TBL] [Abstract][Full Text] [Related]
4. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
[TBL] [Abstract][Full Text] [Related]
5. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
6. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
Kwong YL; Chan V; Wong KF; Chan TK
Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132
[TBL] [Abstract][Full Text] [Related]
7. Dose dependent long-term in vivo remission of AML1/ETO positive acute myeloid leukemia with G-CSF.
Zomas A; Stefanoudaki-Sofianatou K; Fisfis M; Anagnostopoulos NI
Hematology; 2004 Apr; 9(2):107-11. PubMed ID: 15203865
[TBL] [Abstract][Full Text] [Related]
8. Significance of quantitative analysis of AML1/ETO transcripts in peripheral blood stem cells from t(8;21) acute myelogenous leukemia.
Miyamoto T; Nagafuji K; Harada M; Niho Y
Leuk Lymphoma; 1997 Mar; 25(1-2):69-75. PubMed ID: 9130615
[TBL] [Abstract][Full Text] [Related]
9. Not the presence but the amount of clonal DNA detectable in remission of acute myeloid leukemia is predictive for relapse.
Reif SW; Wiesner D; Duell T; Mittermueller J; Schmetzer HM
Eur J Haematol; 2001 Oct; 67(4):207-20. PubMed ID: 11860441
[TBL] [Abstract][Full Text] [Related]
10. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
[TBL] [Abstract][Full Text] [Related]
12. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
13. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
Nucifora G; Rowley JD
Leuk Lymphoma; 1994 Aug; 14(5-6):353-62. PubMed ID: 7812194
[TBL] [Abstract][Full Text] [Related]
14. Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission.
Satake N; Maseki N; Kozu T; Sakashita A; Kobayashi H; Sakurai M; Ohki M; Kaneko Y
Br J Haematol; 1995 Dec; 91(4):892-8. PubMed ID: 8547135
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients.
Morschhauser F; Cayuela JM; Martini S; Baruchel A; Rousselot P; Socié G; Berthou P; Jouet JP; Straetmans N; Sigaux F; Fenaux P; Preudhomme C
J Clin Oncol; 2000 Feb; 18(4):788-94. PubMed ID: 10673520
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia.
Miyamoto T; Nagafuji K; Harada M; Eto T; Fujisaki T; Kubota A; Akashi K; Mizuno S; Takenaka K; Kanaji T
Br J Haematol; 1995 Sep; 91(1):132-8. PubMed ID: 7577620
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.
Inokuchi K; Iwakiri R; Futaki M; Hanawa H; Tanosaki S; Nomura T; Dan K
Leuk Lymphoma; 1998 May; 29(5-6):553-61. PubMed ID: 9643569
[TBL] [Abstract][Full Text] [Related]
18. Persistence of AML1/ETO fusion mRNA in t(8;21) acute myeloid leukemia (AML) in prolonged remission: is there a consensus?
Preudhomme C; Philippe N; Macintyre E; Henic N; Lai JL; Jouet JP; Cosson A; Fenaux P
Leukemia; 1996 Jan; 10(1):186-8. PubMed ID: 8558929
[No Abstract] [Full Text] [Related]
19. Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes.
Barragán E; Bolufer P; Moreno I; Martín G; Nomdedeu J; Brunet S; Fernández P; Rivas C; Sanz MA
Leuk Lymphoma; 2001 Aug; 42(4):747-56. PubMed ID: 11697505
[TBL] [Abstract][Full Text] [Related]
20. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement.
Park KU; Lee DS; Lee HS; Kim CJ; Cho HI
Am J Pathol; 2001 Dec; 159(6):2011-6. PubMed ID: 11733351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]